Article Abstract

Advances in theranostic biomarkers for lung cancer from clinical to molecular pathology

Authors: Paul Hofman


In 2018, lung cancer is the first cause of death by cancer in the world (1). So, it is mandatory to continue to look for more
effective treatments, targeting precisely the biological characteristics of tumors.